Evidence for cytoplasmic P-glycoprotein location associated with increased multidrug resistance and resistance to chemosensitizers

Cancer Research

Volumn 56, Issue 23, 1996, Pages 5435-5442

  Abbaszadegan, Mohammad R ^a,b,c   Cress, Anne E ^a,b   Futscher, Bernard W ^a,b   Bellamy, William T ^a   Dalton, William S ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; GLYCOPROTEIN P; VERAPAMIL; VINCRISTINE;

ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; MYELOMA CELL; PRIORITY JOURNAL; PROTEIN PROCESSING;

ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT, ACTIVE; CELL MEMBRANE; CELL NUCLEUS; CYTOPLASM; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; MULTIPLE MYELOMA; NEOPLASM PROTEINS; P-GLYCOPROTEIN; TUMOR CELLS, CULTURED; VERAPAMIL;

EID: 0030476060     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Beck, W T The cell biology of multiple drug resistance. Biochem. Pharmacol., 36: 2879-2887, 1987.
2. Roninson, I. B. Molecular and cellular biology of multidrug resistance in tumor cells. New York: Plenum Publishing Corp., 1991.
3. Shustik, C , Dalton, W., and Gros, P P-glycoprotein-mediated multidrug resistance in tumor cells: biochemistry, clinical relevance and modulation In: Molecular Aspects of Medicine, pp 1-78 London: Elsevier Science Ltd , 1995.
4. Dalton, W S., Durie, B G., Alberts, D. S., Gerlach, J. H., and Cress, A. E Characterization of a new drug-resistant human myeloma cell line that expresses P-glycoprotein Cancer Res., 46: 5125-5130, 1986.
5. Riordan, J R., and Ling, V. Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability. J. Biol. Chem., 254 12701-12705, 1979
6. Chen, C. J., Chin, J E., Ueda, K , Clark, D P , Pastan, I , Gottesman, M M., and Roninson, I. B. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells Cell, 47: 381-389, 1986
7. Endicott, J. A , and Ling, V The biochemistry of P-glycoprotein-mediated multidrug resistance Annu. Rev. Biochem., 58: 137-171, 1989
8. Chan, H S , Haddad, G , Thorner, P. S , DeBoer, G , Lin, Y P., Ondrusek, N., Yeger, H , and Ling, V. P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N. Engl J Med , 325: 1608-1614, 1991
9. Dalton, W. S Drug resistance modulation in the laboratory and the clinic. Semin Oncol , 20: 64-69, 1993
10. Salmon, S. E., Dalton, W. S., Grogan, T M., Plezia, P., Lehnert, M., Roe, D J., and Miller, T P. Multidrug-resistant myeloma laboratory and clinical effects of verapamil as a chemosensitizer Blood, 78: 44-50, 1991
11. List, A F., Spier, C , Greer, J., Wolff, S., Hutter, J , Dorr, R., Salmon, S., Bater, M., and Dalton, W Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia J Clin. Oncol , 11: 1652-1660, 1993
12. Miller, T. P , Grogan, T M , Dalton, W. S., Spier, C. M., Scheper, R J., and Salmon, S. E. P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil. J. Clin. Oncol., 9: 17-24, 1991.
13. Sikic, B. I. Modulation of multidrug resistance, at the threshold. J. Clin. Oncol., 11: 1629-1635, 1993.
14. Abbaszadegan, M R , Foley, N E., Gleason-Guzman, M. C., and Dalton, W. S. Resistance to the chemosensitizer, verapamil, in a multidrug resistant (MDR) human multiple myeloma cell line. Int J. Cancer, 66: 505-514, 1996.
15. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J , and Rutter, W J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18: 5294-5299, 1979.
16. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular cloning: a laboratory manual. Cold Spring Harbor: Cold Spring Harbor Laboratory, 1989.
17. Futscher, B. W., Blake, L. L., Gerlach, J H , Grogan, T. M , and Dalton, W. S. Quantitative polymerase chain reaction analysis of mdr1 mRNA in multiple myeloma cell lines and clinical specimens. Anal. Biochem., 213: 414-421, 1993.
18. Cleveland, D. W., Lopata, M. A., MacDonald, R. J., Cowan, N. J., Rutter, W J , and Kirschner, M. W. Number and evolutionary conservation of α- and β-tubulin and cytoplasmic β- and γ-actin genes using specific cloned cDNA probes. Cell, 20: 95-105, 1980.
19. Ross, W , Wozniak, A., Smallwood, S., and Yalowich, J. C. DNA damage by VP-16: mechanism and relationship to cytotoxicity In. B. F. Issell, F. M. Muggir and S. K. Carter (eds.), Etoposide (VP-16): Current Status and New Developments, pp. 49-61. New York: Academic Press, Inc., 1984
20. Bellamy, W. T., Dorr, R. T., Dalton, W. S , and Alberts, D S. Direct relation of DNA lesions in multidrug-resistant human myeloma cells to intracellular doxorubicin concentration. Cancer Res., 48. 6360-6364, 1988.
21. Kohn, K. W., and Ewig, R. A. G. Measurement of strand breaks and crosslinks by alkaline elution In: E. C Freidberg and P. C. Hanawalt (eds.), DNA repair: A Laboratory Manual of Research Procedures, pp. 379-401 New York: Marcel Dekker, Inc., 1981
22. Kohn, K W., and Ewig, R. A. DNA-protein crosslinking by trans-platinum(II)diamminedichloride in mammalian cells, a new method of analysis. Biochim. Biophys. Acta, 562: 32-40, 1979.
23. Ross, W E , Glaubiger, D., and Kohn, K. W Qualitative and quantitative aspects of intercalator-induced DNA strand breaks. Biochim. Biophys. Acta, 562: 41-50, 1979.
24. Blobe, G. C., Sachs, C. W., Khan, W. A., Fabbro, D., Stabel, S., Wetsel, W C , Obeid, L. M., Fine, R. L., and Hannun, Y. A. Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-reststant MCF-7 cells: functional significance of enhanced expression of PKC α. J. Biol. Chem., 268: 658-664, 1993.
25. Greenberger, L. M , Williams, S. S , and Horwitz, S B. Biosynthesis of heterogeneous forms of multidrug resistance-associated glycoproteins. J. Biol. Chem., 262: 13685-13689, 1987
26. Orita, M., Iwahana, H., Kanazawa, H., Hayashi, K., and Sekiya, T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms Proc. Natl Acad. Sci. USA, 86. 2766-2770, 1989.
27. Orita, M., Suzuki, Y., Sekiya, T., and Hayashi, K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction Genomics, 5 874-879, 1989.
28. Soto, D , and Sukumar, S. Improved detection of mutations in the p53 gene in human tumors as single-stranded conformation polymorphs and double-stranded heteroduplex DNA. PCR Methods Appl., 2: 96-98, 1992.
29. Tarentino, A. L., Trimble, R. B., and Plummer, T. H., Jr Enzymatic approaches for studying the structure, synthesis, and processing of glycoproteins. Methods Cell Biol., 32: 111-139, 1989.
30. Chauffert, B., Martin, F., Caignard, A., Jeannin, J F., and Leclerc, A. Cytofluorescence localization of adriamycin in resistant colon cancer cells. Cancer Chemother. Pharmacol., 13: 14-18, 1984
31. Choi, K. H., Chen, C. J., Kriegler, M., and Roninson, I. B An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene Cell. 53: 519-529, 1988.
32. Devine, S. E., Ling, V., and Melera, P W. Amino acid substitutions in the sixth transmembrane domain of P-glycoprotem alter multidrug resistance Proc. Natl Acad Sci. USA, 89: 4564-4568, 1992
33. Safa, A. R., Stern, R. K., Choi, K., Agresti, M., Tamai, I., Mehta, N. D., and Roninson, I B Molecular basis of preferential resistance to colchicine in multidrug-resistant human cells conferred by Gly-185-Val-185 substitution in P-glycoprotein Proc. Natl. Acad Sci. USA, 87: 7225-7229, 1990.
34. Gros, P., Dhir, R., Croop, J., and Talbot, F. A single amino acid substitution strongly modulates the activity and substrate specificity of the mouse mdr1 and mdr3 drug efflux pumps. Proc. Natl. Acad Sci. USA, 88: 7289-7293, 1991.
35. Bruggemann, E P , Currier, S J., Gottesman, M M., and Pastan, I. Characterization of the azidopine and vinblastine binding site of P-glycoprotem. J. Biol. Chem , 267: 21020-21026, 1992.
36. Kajiji, S , Dreslin, J A., Grizzuti, K., and Gros, P. Structurally distinct MDR modulators show specific patterns of reversal against P-glycoproteins bearing unique mutations at senne 939/941. Biochemistry, 33: 5041-5048, 1994
37. Skach, W. R., and Lingappa, V R. Amino-terminal assembly of human P-glycoprotein at the endoplasmic reticulum is directed by cooperative actions of two internal sequences. J. Biol. Chem., 268. 23552-23561, 1993.
38. Schinkel, A H , Kemp, S., Dolle, M., Rudenko, G., and Wagenaar, E. N-glycosylation and deletion mutants of the human MDR1 P-glycoprotein J Biol Chem., 268: 7474-7481, 1993
39. Gervasoni, J E., Jr , Fields, S Z , Krishna, S., Baker, M. A., Rosado, M , Thuraisamy, K , Hindenburg, A. A., and Taub, R. N Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy. Cancer Res., 51: 4955-4963, 1991.
40. Willingham, M C , Cornwell, M M, Cardarelli, C. O , Gottesman, M. M., and Pastan, I Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs Cancer Res., 46 5941-5946, 1986.